<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39329140</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2167-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PeerJ</Title><ISOAbbreviation>PeerJ</ISOAbbreviation></Journal><ArticleTitle>Antimicrobial activities of Diltiazem Hydrochloride: drug repurposing approach.</ArticleTitle><Pagination><StartPage>e17809</StartPage><MedlinePgn>e17809</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e17809</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.17809</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The growing concern of antibiotic-resistant microbial strains worldwide has prompted the need for alternative methods to combat microbial resistance. Biofilm formation poses a significant challenge to antibiotic efficiency due to the difficulty of penetrating antibiotics through the sticky microbial aggregates. Drug repurposing is an innovative technique that aims to expand the use of non-antibiotic medications to address this issue. The primary objective of this study was to evaluate the antimicrobial properties of Diltiazem HCl, a 1,5-benzothiazepine Ca<sub>2</sub> <sup>+</sup> channel blocker commonly used as an antihypertensive agent, against four pathogenic bacteria and three pathogenic yeasts, as well as its antiviral activity against the Coxsackie B4 virus (CoxB4).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To assess the antifungal and antibacterial activities of Diltiazem HCl, the well diffusion method was employed, while crystal violet staining was used to determine the anti-biofilm activity. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay was utilized to evaluate the antiviral activity of Diltiazem HCl against the CoxB4 virus.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">This study revealed that Diltiazem HCl exhibited noticeable antimicrobial properties against Gram-positive bacteria, demonstrating the highest inhibition of <i>Staphylococcus epidermidis</i>, followed by <i>Staphylococcus aureus</i>. It effectively reduced the formation of biofilms by 95.1% and 90.7% for <i>S. epidermidis</i>, and <i>S. aureus</i>, respectively. Additionally, the antiviral activity of Diltiazem HCl was found to be potent against the CoxB4 virus, with an IC<sub>50</sub> of 35.8 ± 0.54 μg mL<sup>-1</sup> compared to the reference antiviral Acyclovir (IC<sub>50</sub> 42.71 ± 0.43 μg mL<sup>-1</sup>).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study suggests that Diltiazem HCl, in addition to its antihypertensive effect, may also be a potential treatment option for infections caused by Gram-positive bacteria and the CoxB4 viruses, providing an additional off-target effect for Diltiazem HCl.</AbstractText><CopyrightInformation>© 2024 Alduaij et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Alduaij</LastName><ForeName>Omar K</ForeName><Initials>OK</Initials><AffiliationInfo><Affiliation>Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Rageh K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu Alrub</LastName><ForeName>Sharif</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physics, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zidan</LastName><ForeName>Sabry A H</ForeName><Initials>SAH</Initials><AffiliationInfo><Affiliation>Department of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Assiut-Branch, Assiut, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ</MedlineTA><NlmUniqueID>101603425</NlmUniqueID><ISSNLinking>2167-8359</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EE92BBP03H</RegistryNumber><NameOfSubstance UI="D004110">Diltiazem</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002121">Calcium Channel Blockers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000935">Antifungal Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004110" MajorTopicYN="Y">Diltiazem</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018441" MajorTopicYN="Y">Biofilms</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="Y">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058492" MajorTopicYN="Y">Drug Repositioning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="Y">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002121" MajorTopicYN="N">Calcium Channel Blockers</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013212" MajorTopicYN="N">Staphylococcus epidermidis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000935" MajorTopicYN="N">Antifungal Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006094" MajorTopicYN="N">Gram-Positive Bacteria</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibacterial</Keyword><Keyword MajorTopicYN="N">Antibiotics</Keyword><Keyword MajorTopicYN="N">Antiviral</Keyword><Keyword MajorTopicYN="N">Coxsackie</Keyword><Keyword MajorTopicYN="N">Diltiazem HCl</Keyword><Keyword MajorTopicYN="N">Drug repurposing</Keyword><Keyword MajorTopicYN="N">MTT</Keyword><Keyword MajorTopicYN="N">Staph aureus</Keyword><Keyword MajorTopicYN="N">Staph epidermidis</Keyword><Keyword MajorTopicYN="N">antibiofilm</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>7</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39329140</ArticleId><ArticleId IdType="pmc">PMC11426324</ArticleId><ArticleId IdType="doi">10.7717/peerj.17809</ArticleId><ArticleId IdType="pii">17809</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdelkarem FM, Nafady AM, Allam AE, Mostafa MA, Al Haidari RA, Hassan HA, Zaki MEA, Assaf HK, Kamel MR, Zidan SAH, Sayed AM, Shimizu K. A comprehensive in silico study of new metabolites from Heteroxenia fuscescens with SARS-CoV-2 inhibitory activity. Molecules. 2022;27(21):7369. doi: 10.3390/molecules27217369.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27217369</ArticleId><ArticleId IdType="pmc">PMC9657797</ArticleId><ArticleId IdType="pubmed">36364194</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuhammour W, Habte-Gabr E. Systemic antifungal agents. The Indian Journal of Pediatrics. 2001;68:655–668. doi: 10.2165/00002018-199818020-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002018-199818020-00001</ArticleId><ArticleId IdType="pubmed">11519290</ArticleId></ArticleIdList></Reference><Reference><Citation>Adaramoye OA, Anjos RM, Almeida MM, Veras RC, Silvia DF, Oliveira FA, Cavalcante KV, Araújo IG, Oliveira AP, Medeiros IA. Hypotensive and endothelium-independent vasorelaxant effects of methanolic extract from Curcuma longa L. in rats. Journal of Ethnopharmacology. 2009;124(3):457–462. doi: 10.1016/j.jep.2009.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2009.05.021</ArticleId><ArticleId IdType="pubmed">19481144</ArticleId></ArticleIdList></Reference><Reference><Citation>Alluri R, Kilari EK, Pasala PK, Kopalli SR, Koppula S. Repurposing Diltiazem for its neuroprotective anti-dementia role against intra-cerebroventricular streptozotocin-induced sporadic Alzheimer’s disease-type rat model. Life. 2023;13(8):1688. doi: 10.3390/life13081688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13081688</ArticleId><ArticleId IdType="pmc">PMC10455909</ArticleId><ArticleId IdType="pubmed">37629545</ArticleId></ArticleIdList></Reference><Reference><Citation>Bariwal JB, Upadhyay KD, Manvar AT, Trivedi JC, Singh JS, Jain KS, Shah AK. 1,5-Benzothiazepine, a versatile pharmacophore: a review. European Journal of Medicinal Chemistry. 2008;43(11):2279–2290. doi: 10.1016/j.ejmech.2008.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2008.05.035</ArticleId><ArticleId IdType="pubmed">18639369</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandia A, Singh R, Singh D, Laxkar A, Sivpuri A. Regioselective synthesis of diltiazem analogue pyrazolo [4,3-c][1,5] benzothiazepines and antifungal activity. Phosphorus, Sulfur, and Silicon. 2010;185(12):2472–2479.</Citation></Reference><Reference><Citation>Elkhatib WF, Haynes VL, Noreddin AM. Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium channel blockers in vitro. Journal of Chemotherapy. 2009;21(2):135–143. doi: 10.1179/joc.2009.21.2.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/joc.2009.21.2.135</ArticleId><ArticleId IdType="pubmed">19423465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujioka Y, Nishide S, Ose T, Suzuki T, Kato I, Fukuhara H, Fujioka M, Horiuchi K, Satoh AO, Nepal P, Kashiwagi S, Wang J, Horiguchi M, Sato Y, Paudel S, Nanbo A, Miyazaki T, Hasegawa H, Maenaka K, Ohba Y. A sialylated voltage-dependent Ca2+ channel binds hemagglutinin and mediates influenza A virus entry into mammalian cells. Cell Host &amp; Microbe. 2018;23(6):809–818. doi: 10.1016/j.chom.2018.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.04.015</ArticleId><ArticleId IdType="pubmed">29779930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazina EV, Harrison DN, Jefferies M, Tan H, Williams D, Anderson DA, Petrou S. Ion transport blockers inhibit human rhinovirus 2 release. Antiviral Research. 2005;67(2):98–106. doi: 10.1016/j.antiviral.2005.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2005.05.003</ArticleId><ArticleId IdType="pubmed">16054245</ArticleId></ArticleIdList></Reference><Reference><Citation>Glajzner P, Bernat A, Jasińska-Stroschein M. Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning. Frontiers in Pharmacology. 2024;15:1397602. doi: 10.3389/fphar.2024.1397602.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2024.1397602</ArticleId><ArticleId IdType="pmc">PMC11193365</ArticleId><ArticleId IdType="pubmed">38910882</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfraind T. Discovery and development of calcium channel blockers. Frontiers in Pharmacology. 2017;8:259145. doi: 10.3389/fphar.2017.00286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2017.00286</ArticleId><ArticleId IdType="pmc">PMC5447095</ArticleId><ArticleId IdType="pubmed">28611661</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochman D, Louie B, Bailey R. Determination of patient quality of life following severe acute pancreatitis. Canadian Journal of Surgery. 2006;49(2):101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207533</ArticleId><ArticleId IdType="pubmed">16630420</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Ramsingh AI. Coxsackievirus-induced pancreatitis. Viral Immunology. 2004;17(3):358–369. doi: 10.1089/vim.2004.17.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.358</ArticleId><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi A, Moradi MT, Saeedi M, Asgari S, Rafieian-Kopaei M. Antiviral activity of Quercus persica L.: high efficacy and low toxicity. Advanced Biomedical Research. 2013;2(2):1–6. doi: 10.4103/2277-9175.109722.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2277-9175.109722</ArticleId><ArticleId IdType="pmc">PMC3905353</ArticleId><ArticleId IdType="pubmed">24516836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur R, Lang DK, Singh H, Arora A, Garg N, Saini B. Repurposing of various current medicines as radioprotective agents. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2023;23(10):1104–1121. doi: 10.2174/1871520622666220404090049.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871520622666220404090049</ArticleId><ArticleId IdType="pubmed">35379128</ArticleId></ArticleIdList></Reference><Reference><Citation>Khales P, Keyvani H, Ataei-Pirkooh A, Saghafi MM, Bokharaei-Salim F, Ghorbani S, Monavari SH, Kiani SJ, Esghaei M, Farahmand M, Sayyahfar S, Khanaliha K, Habib Z, Tavakoli A. Amlodipine and diltiazem significantly repress human rotavirus infection in vitro. Recent Advances in Anti-Infective Drug Discovery Formerly Recent Patents on Anti-Infective Drug Discovery. 2023;18(3):205–214. doi: 10.2174/2772434418666221107105624.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2772434418666221107105624</ArticleId><ArticleId IdType="pubmed">36345239</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruszewska H, Zareba T, Tyski S. Examination of antibacterial and antifungal activity of selected non-antibiotic products. Acta Poloniae Pharmaceutica—Drug Research. 2008;65(6):779–782.</Citation><ArticleIdList><ArticleId IdType="pubmed">19172867</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Zhang J, Pan J, Wu Z, Hu D, Song B. Design, synthesis, and antiviral activities of 1,5-benzothiazepine derivatives containing pyridine moiety. European Journal of Medicinal Chemistry. 2017;125:657–662. doi: 10.1016/j.ejmech.2016.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2016.09.069</ArticleId><ArticleId IdType="pubmed">27721151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P. Acyclovir. Pediatric Infectious Disease. 2013;5(4):178–180. doi: 10.1016/j.pid.2013.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pid.2013.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal R, Sharma S, Chhibber S, Aggarwal S, Gupta V, Harjai K. Correlation between serogroup, in vitro biofilm formation and elaboration of virulence factors by uropathogenic Pseudomonas aeruginosa. FEMS Immunology &amp; Medical Microbiology. 2010;58(2):237–243. doi: 10.1111/j.1574-695X.2009.00627.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2009.00627.x</ArticleId><ArticleId IdType="pubmed">19930457</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanta YK, Biswas K, Jena SK, Hashem A, Abd_Allah EF, Mohanta TK. Anti-biofilm and antibacterial activities of silver nanoparticles synthesized by the reducing activity of phytoconstituents present in the Indian medicinal plants. Frontiers in Microbiology. 2020;11:1143. doi: 10.3389/fmicb.2020.01143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01143</ArticleId><ArticleId IdType="pmc">PMC7324531</ArticleId><ArticleId IdType="pubmed">32655511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubarack HM, Doss A, Vijayasanthi M, Venkataswamy R. Antibacterial activity of some herbal extracts against Staphylococcus aureus isolated from Bovine Mastitis. Journal of Pharmacy Research. 2012;5(2):2428–2430.</Citation></Reference><Reference><Citation>Pant S, Avinash RJ, Yadav M. Synthesis of 1, 5-benzothiazepines: Part 43: synthesis and antimicrobial evaluation of 8-substituted-2, 5-dihydro-2-(3-chlorophenyl/4-chlorophenyl)-4-(4-methylephenyle)-1, 5 benzothiazepines. Chemistry. 2014;1(7):25–30.</Citation></Reference><Reference><Citation>Pizzorno A, Padey B, Dubois J, Julien T, Traversier A, Dulière V, Brun P, Lina B, Rosa-Calatrava M, Terrier O. In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2. Antiviral Research. 2020;181:104878. doi: 10.1016/j.antiviral.2020.104878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104878</ArticleId><ArticleId IdType="pmc">PMC7361110</ArticleId><ArticleId IdType="pubmed">32679055</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzorno A, Terrier O, Nicolas de Lamballerie C, Julien T, Padey B, Traversier A, Roche M, Hamelin M, Rhéaume C, Croze S, Escuret V, Poissy J, Linal B, Legras-Lachuer C, Textoris J, Boivin G, Rosa-Calatrava M. Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures. Frontiers in Immunology. 2019;10:60. doi: 10.3389/fimmu.2019.00060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00060</ArticleId><ArticleId IdType="pmc">PMC6361841</ArticleId><ArticleId IdType="pubmed">30761132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan AM, Shehata RM, El-Sheikh HH, Ameen F, Stephenson SL, Zidan SA, Al-Bedak OA. Exploitation of sugarcane bagasse and environmentally sustainable production, purification, characterization, and application of lovastatin by Aspergillus terreus AUMC 15760 under solid-state conditions. Molecules. 2023;28(10):4048. doi: 10.3390/molecules28104048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28104048</ArticleId><ArticleId IdType="pmc">PMC10222103</ArticleId><ArticleId IdType="pubmed">37241788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramadan AMAA, Zidan SAH, Shehata RM, El-Sheikh HH, Ameen F, Stephenson SL, Al-Bedak OAHM. Antioxidant, antibacterial, and molecular docking of methyl ferulate and oleic acid produced by Aspergillus pseudodeflectus AUMC 15761 utilizing wheat bran. Scientific Reports. 2024;14(1):3183. doi: 10.1038/s41598-024-52045-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-52045-z</ArticleId><ArticleId IdType="pmc">PMC10850474</ArticleId><ArticleId IdType="pubmed">38326360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro E, Costa B, Vasques-Nóvoa F, Vale N. In vitro drug repurposing: focus on vasodilators. Cells. 2023;12(4):671. doi: 10.3390/cells12040671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12040671</ArticleId><ArticleId IdType="pmc">PMC9954697</ArticleId><ArticleId IdType="pubmed">36831338</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AD. Types of antibiotics and synthetic antimicrobial agents. Hugo and Russell’s Pharmaceutical Microbiology. 2004;(10):152–186.</Citation></Reference><Reference><Citation>Saini RK, Joshi YC, Joshi P. Solvent-free synthesis of some 1, 5-benzothiazepines and benzodiazepines and their antibacterial activity. Phosphorus, Sulfur, and Silicon and the Related Elements. 2008;183(9):2181–2190. doi: 10.1080/10426500701852661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10426500701852661</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem SH, El-Maraghy SS, Abdel-Mallek AY, Abdel-Rahman MA, Hassanein EH, Al-Bedak OA, El-Aziz FEZAA. The antimicrobial, antibiofilm, and wound healing properties of ethyl acetate crude extract of an endophytic fungus Paecilomyces sp.(AUMC 15510) in earthworm model. Scientific Reports. 2022;12(1):19239. doi: 10.1038/s41598-022-23831-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-23831-4</ArticleId><ArticleId IdType="pmc">PMC9649741</ArticleId><ArticleId IdType="pubmed">36357560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkisova S, Patrauchan MA, Berglund D, Nivens DE, Franklin MJ. Calcium-induced virulence factors associated with the extracellular matrix of mucoid Pseudomonas aeruginosa biofilms. Journal of Bacteriology. 2005;187(13):4327–4337. doi: 10.1128/JB.187.13.4327-4337.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.187.13.4327-4337.2005</ArticleId><ArticleId IdType="pmc">PMC1151780</ArticleId><ArticleId IdType="pubmed">15968041</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh TU, Parida S, Lingaraju MC, Kesavan M, Kumar D, Singh RK. Drug repurposing approach to fight COVID-19. Pharmacological Reports. 2020;72:1479–1508. doi: 10.1007/s43440-020-00155-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-020-00155-6</ArticleId><ArticleId IdType="pmc">PMC7474498</ArticleId><ArticleId IdType="pubmed">32889701</ArticleId></ArticleIdList></Reference><Reference><Citation>Soni J, Sinha S, Pandey R. Understanding bacterial pathogenicity: a closer look at the journey of harmful microbes. Frontiers in Microbiology. 2024;15:1370818. doi: 10.3389/fmicb.2024.1370818.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2024.1370818</ArticleId><ArticleId IdType="pmc">PMC10912505</ArticleId><ArticleId IdType="pubmed">38444801</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepanovs D, Jure M, Gosteva M, Popelis J, Kiselovs G, Mishnev A. Crystal structures and physicochemical properties of diltiazem base and its acetylsalicylate, nicotinate and L-malate salts. CrystEngComm. 2016;18(7):1235–1241. doi: 10.1039/C5CE01204J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5CE01204J</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. International Journal of Medical Microbiology. 2002;292(2):107–113. doi: 10.1078/1438-4221-00196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/1438-4221-00196</ArticleId><ArticleId IdType="pubmed">12195733</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor DJ, Hamid SM, Andres AM, Saadaeijahromi H, Piplani H, Germano JF, Song Y, Sawaged S, Feuer R, Pandol SJ, Sin J. Antiviral effects of menthol on Coxsackievirus B. Viruses. 2020;12(4):373. doi: 10.3390/v12040373.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040373</ArticleId><ArticleId IdType="pmc">PMC7232514</ArticleId><ArticleId IdType="pubmed">32231022</ArticleId></ArticleIdList></Reference><Reference><Citation>Valgas C, Souza SMD, Smânia EF, Smânia A., Jr Screening methods to determine antibacterial activity of natural products. Brazilian Journal of Microbiology. 2007;38:369–380.</Citation></Reference><Reference><Citation>Weth FR, Hoggarth GB, Weth AF, Paterson E, White MP, Tan ST, Gray C. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy. British Journal of Cancer. 2024;130(5):703–715. doi: 10.1038/s41416-023-02502-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41416-023-02502-9</ArticleId><ArticleId IdType="pmc">PMC10912636</ArticleId><ArticleId IdType="pubmed">38012383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zidan SA, Abdelhamid RA, Al-Hammady M, Fouad MA, Matsunami K, Orabi MA. Cytotoxic polyhydroxy sterols from the Egyptian Red Sea soft coral Sarcophyton acutum. Fitoterapia. 2020;147:104765, 1–8. doi: 10.1016/j.fitote.2020.104765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fitote.2020.104765</ArticleId><ArticleId IdType="pubmed">33122132</ArticleId></ArticleIdList></Reference><Reference><Citation>Zidan SA, Orabi MA, Mustafa MA, AAl-Hammady M, Kamel MS. Anti-HSV-1 and hepatoprotective activities of the Soft coral Sarcophyton acutum from the Red Sea. Journal of Pharmacognosy and Phytochemistry. 2016;5(5):247–251.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>